ReCode Therapeutics Funding: $570M Raised, Series B (2025)
ReCode Therapeutics is a Biotech company based in Menlo Park, CA. It has raised $570M in total funding. Latest round: Series B.
ReCode Therapeutics funding overview
ReCode Therapeutics is a Biotech company based in Menlo Park, CA. ReCode Therapeutics has raised $570M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series B announced in September 2025. The round record for ReCode Therapeutics runs through 2025; nothing later has been disclosed. Investors on record include OrbiMed, Colt Ventures, InterWest, MPM Capital, Pfizer Venture Investments, Vida Ventures and 9 others. 15 distinct backers are named across the disclosed rounds.
ReCode Therapeutics at a glance
Total raised
$570M
Latest round
Series B
Latest round date
September 2025
Industry
Biotech
Headquarters
Menlo Park, CA
Notable investors
OrbiMed, Colt Ventures, InterWest, MPM Capital, Pfizer Venture Investments, Vida Ventures, SAM Altman, Hunt Technology Ventures
Frequently asked about ReCode Therapeutics funding
How much has ReCode Therapeutics raised?
ReCode Therapeutics has raised $570M in total disclosed funding across the rounds on record.
Who has invested in ReCode Therapeutics?
OrbiMed, Colt Ventures, InterWest, MPM Capital, Pfizer Venture Investments, Vida Ventures are named among the investors backing ReCode Therapeutics.
What was the latest ReCode Therapeutics funding round?
The most recent disclosed round is a Series B, announced in September 2025.
Where is ReCode Therapeutics based?
ReCode Therapeutics is based in Menlo Park, CA.
What sector does ReCode Therapeutics operate in?
ReCode Therapeutics is tracked under Biotech from Menlo Park, CA, with $570M in disclosed funding.
When did ReCode Therapeutics last raise?
The last disclosed ReCode Therapeutics round closed in September 2025 at Series B.
Every ReCode Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies in Menlo Park at a similar stage.
